Jinqi Lu

Title: Jinqi Lu: Innovator in Pharmaceutical Compounds

Introduction

Jinqi Lu is a notable inventor based in Somerville, NJ (US), recognized for his contributions to the field of pharmaceuticals. He has been granted 2 patents that focus on innovative compounds aimed at treating various medical conditions.

Latest Patents

One of his latest patents is titled "Pyrimidine amide compounds as PGDS inhibitors." This invention is directed to a compound of formula (I), wherein R, R, and L are defined as specified in the patent. The pharmaceutical composition comprising this compound is intended for the treatment of allergic and inflammatory disorders, particularly conditions such as allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD).

Another significant patent is "3-piperidinylisochroman-5-ols as dopamine agonists." This invention provides compounds of formula I, which includes a stereoisomer or a pharmaceutically acceptable salt thereof. The patent outlines a method for treating dopamine-related neurological disorders, including neurological, psychological, cardiovascular, cognitive, or attention disorders, as well as substance abuse and addictive behavior. The treatment involves administering a therapeutically effective amount of the compounds to patients in need.

Career Highlights

Jinqi Lu is currently employed at Aventis Pharmaceuticals Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has significantly impacted the field of medicine, particularly in addressing complex health issues.

Collaborations

Some of his notable coworkers include Suzanne C Aldous and John Ziqi Jiang, who contribute to the collaborative environment at Aventis Pharmaceuticals Inc.

Conclusion

Jinqi Lu's innovative work in pharmaceutical compounds demonstrates his commitment to advancing medical treatments. His patents reflect a deep understanding of complex health issues and a dedication to improving patient outcomes.